HSBC Global Asset Management (HSBC GAM) has recruited two healthcare experts with the view of launching a sustainable equity fund investing in the sector.
Based in Switzerland, Dr Nathalie Flury and Dr Michael Schröter will co-head the firm’s sustainable healthcare equity team and be responsible for establishing a sustainable healthcare strategy.
“Past strategies to make healthcare sustainable are struggling to work and we are reaching a tipping point that jeopardises healthcare sustainability,” Flury and Schröter said in a statement.
“Healthcare budget increases beyond GDP growth are unlikely and patients are being increasingly denied treatments because of high costs. Shifting demographics and therapeutic innovation are also increasing the demand for healthcare and innovative therapies which come with increasingly high price tags.”
The strategy will form the basis of a fund investing in healthcare companies in the future.
Both doctors join from Viopas Partners AG, a Swiss asset manager specializing in sustainable healthcare investments.
Before joining Viopas, Flury was the portfolio manager for Pictet Asset Management’s health and biotech fund. She has also managed similar funds at GAM and Clariden, also based in Switzerland.
Schröter’s previous roles include head of personalized reimbursement models at Roche and head of the oncology diagnostic research and development centre at US pharmaceutical Eli Lilly in Singapore.
The proposed fund will invest in a portfolio of companies offering affordable innovation in the healthcare sector, with a focus on good health and wellbeing, the third goal of the UN’s Sustainability Development Goals.
© 2021 funds europe
